Back to top
more

Merck & Co. (MRK)

(Delayed Data from NYSE)

$103.75 USD

103.75
7,529,972

-0.13 (-0.13%)

Updated Dec 8, 2023 04:00 PM ET

After-Market: $103.56 -0.19 (-0.18%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.96%
2Buy17.61%
3Hold8.96%
4Sell4.80%
5Strong Sell2.32%
S&P50010.64%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value A Growth C Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 20% (51 out of 251)

Industry: Large Cap Pharmaceuticals

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for MRK

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Merck & Co, Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018
Assets          
Cash & Equivalents 13,192 8,096 8,062 10,450 8,864
Receivables 9,450 9,230 7,851 6,778 7,071
Notes Receivable 0 0 0 0 0
Inventories 5,911 5,953 6,310 5,978 5,440
Other Current Assets 7,169 6,987 5,541 4,277 4,500
Total Current Assets 35,722 30,266 27,764 27,483 25,875
Net Property & Equipment 21,422 19,279 17,986 15,053 13,291
Investments & Advances 1,015 370 785 1,469 6,233
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 41,473 44,197 34,842 33,621 29,684
Deposits & Other Assets 9,528 11,582 10,211 6,771 7,554
Total Assets 109,160 105,694 91,588 84,397 82,637
Liabilities & Shareholders Equity 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018
Notes Payable 1,946 2,412 6,431 3,610 5,308
Accounts Payable 4,264 4,609 4,594 3,738 3,318
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 14,159 13,859 13,053 12,549 10,151
Income Taxes Payable 1,986 1,224 1,575 736 1,971
Other Current Liabilities 1,884 1,768 1,674 1,587 1,458
Total Current Liabilities 24,239 23,872 27,327 22,220 22,206
Mortgages 0 0 0 0 0
Deferred Taxes/Income 1,795 3,441 1,015 1,470 1,702
Convertible Debt 0 0 0 0 0
Long-Term Debt 28,745 30,690 25,360 22,736 19,806
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 8,323 9,434 12,482 11,970 12,041
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 63,102 67,437 66,184 58,396 55,755
Shareholders Equity 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018
Preferred Stock 0 0 0 0 0
Common Stock (Par) 1,788 1,788 1,788 1,788 1,788
Capital Surplus 44,379 44,238 39,588 39,660 38,808
Retained Earnings 61,081 53,696 47,362 46,602 42,579
Other Equity -4,701 -4,356 -6,547 -6,099 -5,364
Treasury Stock 56,489 57,109 56,787 55,950 50,929
Total Shareholder's Equity 46,058 38,257 25,404 26,001 26,882
Total Liabilities & Shareholder's Equity 109,160 105,694 91,588 84,397 82,637
Total Common Equity 46,058 38,257 25,404 26,001 26,882
Shares Outstanding 2,535.40 2,527.60 2,530.00 2,545.90 2,600.30
Book Value Per Share 18.17 15.14 10.04 10.21 10.34

Fiscal Year End for Merck & Co, Inc falls in the month of December.

All items in Millions except Per Share data.

9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Assets          
Cash & Equivalents 8,773 6,378 10,387 13,192 11,248
Receivables 10,394 11,030 10,415 9,450 9,482
Notes Receivable 0 0 0 0 0
Inventories 6,131 5,930 5,863 5,911 5,614
Other Current Assets 6,656 6,639 6,737 7,169 7,217
Total Current Assets 31,954 29,977 33,402 35,722 33,561
Net Property & Equipment 22,526 22,231 21,758 21,422 20,424
Investments & Advances 1,306 1,214 1,290 1,015 984
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 40,382 40,860 41,066 41,473 42,528
Deposits & Other Assets 10,559 10,187 10,280 9,528 9,584
Total Assets 106,727 104,469 107,796 109,160 107,081
Liabilities & Shareholders Equity 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Notes Payable 887 2,839 2,672 1,946 1,936
Accounts Payable 3,509 3,442 3,680 4,264 3,371
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 14,840 13,747 13,000 14,159 14,222
Income Taxes Payable 1,981 1,489 1,872 1,986 1,698
Other Current Liabilities 1,877 1,877 1,907 1,884 1,771
Total Current Liabilities 23,094 23,394 23,131 24,239 22,998
Mortgages 0 0 0 0 0
Deferred Taxes/Income 1,018 996 1,442 1,795 2,417
Convertible Debt 0 0 0 0 0
Long-Term Debt 33,972 34,072 28,074 28,745 28,482
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 7,343 8,244 8,323 8,660
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 65,427 65,727 60,891 63,102 62,557
Shareholders Equity 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Preferred Stock 0 0 0 0 0
Common Stock (Par) 1,788 1,788 1,788 1,788 1,788
Capital Surplus 44,358 44,219 44,467 44,379 44,243
Retained Earnings 57,082 54,198 62,039 61,081 59,928
Other Equity -4,862 -4,851 -4,812 -4,701 -4,677
Treasury Stock 57,066 56,612 56,577 56,489 56,758
Total Shareholder's Equity 41,300 38,742 46,905 46,058 44,524
Total Liabilities & Shareholder's Equity 106,727 104,469 107,796 109,160 107,081
Total Common Equity 41,300 38,742 46,905 46,058 44,524
Shares Outstanding 2,537.50 2,537.40 2,538.50 2,535.40 2,533.20
Book Value Per Share 16.28 15.27 18.48 18.17 17.58